Development Aspects, Physiochemical Characteristics, Pharmaceutical Requirements and Different Manufacturing Procedures for Dry Powder Inhalation Formulations
Abstract
Keywords
Full Text:
PDFReferences
Telko MJ, Hickey AJ. Dry Powder Inhaler Formulation. Respir Care. 2005; 50(9): 1209–27p.
Maghsoudi S, Taghavi Shahraki B, et al. The Colorful World of Carotenoids: A Profound Insight on Therapeutics and Recent Trends in Nano Delivery Systems. Crit Rev Food Sci Nutr. 2021; 1–40p.
Lavorini F. The Challenge of Delivering Therapeutic Aerosols to Asthma Patients. Int Sch Res Notices. 2013; 2013: 102418p.
Verma RK, Garg S. Drug Delivery Technologies and Future Directions. Pharma Technol. 2001; 25(2): 1–4p.
Yurdasiper A, Arıcı M, Ozyazici M. Nanopharmaceuticals: Application in Inhaler Systems. Emerging Nanotechnologies in Immunology. Elsevier; 2018; 165–201p.
Zhang X. The Development of a Noval Dry Powder Inhaler. Int J Pharma. 2012; 431(1–2): 45–52p.
Weers JG, Bell J, et al. Pulmonary Formulations: What Remains to be Done? Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2010; 23(Suppl 2): S-5–23p.
Naik S, Mukherjee R, Chaudhuri B. Triboelectrification: A Review of Experimental and Mechanistic Modeling Approaches with a Special Focus on Pharmaceutical Powders. Int J Pharm. 2016; 510(1): 375–85p.
Telko MJ. Investigation of Electrostatic Charging Phenomena in Dry Powder Inhalers and the Effect on Deposition. University Library; Mar 21, 2019. [online] Available from: https://cdr.lib.unc.edu/concern/dissertations/9w032362g
Abuzar SM, Hyun SM, et al. Enhancing the Solubility and Bioavailability of Poorly Water-Soluble Drugs Using Supercritical Antisolvent (SAS) Process. Int J Pharm. 2018; 538(1–2): 1–3p.
Weiss C, McLoughlin P, Cathcart H. Characterisation of Dry Powder Inhaler Formulations Using Atomic Force Microscopy. Int J Pharm. Oct 15, 2015; 494(1): 393–407p. 12. Tse JY, Kadota K, Imakubo T, Uchiyama H, Tozuka Y. Enhancement of the Extra-Fine Particle Fraction of Levofloxacin Embedded in Excipient Matrix Formulations for Dry Powder Inhaler Using Response Surface Methodology. Eur J Pharm Sci. 2021; 156: 105600p.
Baklanov A, Sørensen JH. Parameterisation of Radio Nuclide Deposition in Atmospheric Long-Range Transport Modelling. Physics and Chemistry of the Earth, Part B: Hydrology, Oceans and Atmosphere. 2001; 26(10): 787–99p.
Cyrys J, Stölzel M, Heinrich J, et al. Elemental Composition and Sources of Fine and Ultrafine Ambient Particles in Erfurt, Germany. Sci Total Environ. 2003; 305(1–3): 143–56p.
Pilcer G, Wauthoz N, Amighi K. Lactose Characteristics and the Generation of the Aerosol. Adv Drug Deliv Rev. Mar 15, 2012; 64(3): 233–56p.
Jain H, Bairagi A, Srivastava S, Singh SB, Mehra NK. Recent Advances in the Development of Microparticles for Pulmonary Administration. Drug Discov Today. 2020; S1359-6446(20)30298-1.
Kubavat HA. The Influence of Crystallisation on the Mechanical and Interfacial Properties of Active Pharmaceutical Ingredients. Doctoral Dissertation. University of Bath; Jun 1, 2019. [Online] Available from: https://researchportal.bath.ac.uk/en/studentTheses/the-influence-of-crystallisation-on-the-mechanical-and-interfacia. 18. Meiring JJ. Ausdem Institut für umweltmedizinische Forschung (IUF) an der Heinrich-Heine-Universität Düsseldorf.
Chow AH, Tong HH, Chattopadhyay P, Shekunov BY. Particle Engineering for Pulmonary Drug Delivery. Pharm Res. 2007; 24(3): 411–37p.
Pilcer G, Amighi K. Formulation Strategy and Use of Excipients in Pulmonary Drug Delivery. Int J Pharm. 2010; 392(1–2): 1–9p.
Nokhodchi A, Martin GP, editors. Pulmonary Drug Delivery: Advances and Challenges. Wiley; 2015.
Refbacks
- There are currently no refbacks.
Copyright (c) 2020 Research & Reviews: A Journal of Drug Formulation, Development and Production